Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
ImpriMed uses AI-driven precision medicine to help oncologists and veterinarians identify the most effective drugs for individual patients, including those with canine and feline blood cancers. The company also provides ex vivo cell-based analytics services to pharmaceutical companies to accelerate oncology drug development.
Parse Score